Scinai Immunotherapeutics Ltd. Quarterly Common Stock, Shares, Issued from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Scinai Immunotherapeutics Ltd. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2021 to Q2 2024.
  • Scinai Immunotherapeutics Ltd. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 3.35B shares, a 130% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.35B +1.9B +130% Jun 30, 2024 6-K 2024-09-09
Q4 2023 1.86B +868M +87.7% Dec 31, 2023 6-K 2024-09-09
Q2 2023 1.45B Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 1.31B Mar 31, 2023 10-Q 2023-05-15
Q4 2022 989M +250M +33.9% Dec 31, 2022 20-F 2024-05-15
Q4 2021 739M Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.